Description
Hersima 150mg Injection is a targeted therapy used in the treatment of certain types of cancer. Its active ingredient, Trastuzumab, is a monoclonal antibody that specifically targets the HER2 protein, which is overexpressed in some cancer cells. By binding to HER2, Hersima inhibits the growth and proliferation of these cancer cells. It is indicated for the treatment of HER2-positive breast cancer and HER2-positive metastatic gastric or gastroesophageal junction adenocarcinoma. The dosage and administration of Hersima 150mg Injection should be determined by a qualified healthcare professional based on the patient’s condition and response to treatment. Common side effects may include fever, chills, nausea, vomiting, diarrhea, and fatigue. Less common but serious side effects can occur, so it is crucial to discuss any concerns with your doctor. Hersima 150mg Injection should be stored at 2°C to 8°C and protected from light. Do not freeze.
